Filter
2716
Filtered Results: 2716
Text search:
TB
prevalence
Featured
Recommendations
210
New Publications
800
Language
Document type
No document type
1862
Studies & Reports
350
Guidelines
264
Strategic & Response Plan
77
Manuals
75
Situation Updates
41
Fact sheets
19
Training Material
17
Infographics
9
Resource Platforms
2
Countries / Regions
India
135
Kenya
100
Western and Central Europe
85
South Africa
75
Ethiopia
66
Uganda
63
Global
60
Zambia
59
Nepal
58
Tanzania
55
Nigeria
52
Malawi
52
Sierra Leone
47
Eastern Europe
47
Rwanda
46
Liberia
44
Lesotho
43
Africa
43
Myanmar / Burma
41
Ghana
37
Latin America and the Carribbean
36
Namibia
36
Indonesia
33
Ukraine
31
Cambodia
30
Bangladesh
30
Zimbabwe
28
Philippines
28
Asia
27
Paraguay
23
Colombia
21
South–East Asia Region
21
Mozambique
20
Botswana
20
Peru
19
Argentina
19
Russia
16
East and Southern Africa
15
Senegal
13
Eswatini/ Swaziland
12
Germany
11
Bolivia
11
South Sudan
11
El Salvador
10
Burkina Faso
10
Venezuela
10
West and Central Africa
10
Pakistan
10
Benin
9
Middle East and North Africa
9
Haiti
8
Albania
7
Congo, Democratic Republic of
7
Tajikistan
6
Guinea
6
Armenia
6
Georgia
6
Ecuador
6
Syria
5
Brazil
5
Uruguay
4
Southern Africa
4
Moldova
4
Sudan
4
Central African Republic
4
North Macedonia
3
Thailand
3
Chile
3
Cameroon
3
Iran
3
Estonia
3
Afghanistan
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Lebanon
3
Somalia
3
Madagascar
3
Timor Leste/ East Timor
2
Laos
2
Burundi
2
USA
2
Jordan
2
North America
2
Vietnam
2
Nicaragua
2
Sri Lanka
2
Yemen
2
Romania
2
Iraq
2
Guatemala
2
Switzerland
1
Mexico
1
Gambia
1
Singapore
1
Niger
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Papua New Guinea
1
Djibouti
1
Egypt
1
Palestine
1
Poland
1
Honduras
1
Mali
1
Angola
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
1292
Clinical Guidelines
184
Public Health
97
Women & Child Health
69
Key Resources
34
Capacity Building
22
Pharmacy & Technologies
21
Toolboxes
TB
629
HIV
419
AMR
96
Mental Health
69
COVID-19
66
NTDs
50
NCDs
42
Disability
29
Caregiver
28
Global Health Education
28
Refugee
27
Pharmacy
24
Polio
20
Ebola
19
Planetary Health
18
Conflict
17
Health Financing Toolbox
14
Rapid Response
13
Natural Hazards
11
Social Ethics
3
Cholera
2
Zika
2
South Sudan
1
Infectious diseases are constantly in transition. New diseases develop, known dis-eases become widespread or reemerge, and occasionally a disease is eradicated.Infectious diseases such as HIV, tuberculosis, and cholera are significant causes ofillness and death in many parts of the world. Health car...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020.
This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level...
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec...
Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The Africa Centres fo...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antibiotic resistance is no longer a concern for the distant future but is a pressing issue, both globally and in Nepal. As part of global effort to preserve the effectiveness of antibiotics, the Global Antibiotic Resistance Partnership (GARP)-Nepal was established to doc...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
Infection Prevention and Control Programmes
January 2020
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
